BioStock: Invent Medic remains active in femtech consolidation going forward – CEO
After a strong first quarter, Invent Medic follows the trend and reports sales of more than 2 MSEK for the second quarter of 2023. CEO Anna Lindström tells BioStock about the positive sales trend and how she views the opportunities for further acquisitions in the women’s health sector.
Read the full article at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se